Early prosthetic valve endocarditis complicating repeated attempts at CoreValve implantation

J Invasive Cardiol. 2011 Dec;23(12):E291-2.

Abstract

Transcatheter aortic valve implantation is emerging as a promising, effective therapy for high-risk patients not eligible to undergo surgical aortic valve replacement. Infection complications have only rarely been reported. We report a case of probable endocarditis caused by coagulase-negative Staphylococcus following repeated attempts at implantation of a CoreValve bioprosthesis.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Aortic Valve Stenosis / surgery*
  • Bioprosthesis / adverse effects
  • Bioprosthesis / microbiology
  • Cardiac Catheterization
  • Echocardiography, Transesophageal
  • Endocarditis / diagnosis
  • Endocarditis / drug therapy
  • Endocarditis / etiology*
  • Follow-Up Studies
  • Heart Valve Prosthesis / adverse effects*
  • Heart Valve Prosthesis / microbiology
  • Humans
  • Male
  • Prosthesis-Related Infections / diagnosis
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / etiology*
  • Reoperation / adverse effects*
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / etiology*
  • Staphylococcus epidermidis / isolation & purification

Substances

  • Anti-Bacterial Agents